Forsta Ap Fonden Eli Lilly & CO Transaction History

Forsta Ap Fonden

$12.8 Billion
Q3 2024

A detailed history of Forsta Ap Fonden transactions in Eli Lilly & CO stock. As of the latest transaction made, Forsta Ap Fonden holds 211,951 shares of LLY stock, worth $159 Million. This represents 1.47% of its overall portfolio holdings.

Number of Shares

211,951

Previous 194,251 9.11%

Holding current value

$159 Million

Previous $176 Million 6.77%

% of portfolio

1.47%

Previous 1.58%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$772.14 - $960.02 $13.7 Million - $17 Million	17,700 Added 9.11%	211,951 $188 Million
Q2 2024 Aug 08, 2024	SELL	$724.87 - $909.04 $13 Million - $16.3 Million	-17,900 Reduced 8.44%	194,251 $176 Million
Q1 2024 May 07, 2024	BUY	$592.2 - $792.28 $8.71 Million - $11.6 Million	14,700 Added 7.44%	212,151 $165 Million
Q4 2023 Feb 06, 2024	BUY	$525.19 - $619.13 $2.05 Million - $2.41 Million	3,900 Added 2.01%	197,451 $115 Million
Q3 2023 Oct 25, 2023	BUY	$434.7 - $599.3 $173,880 - $239,719	400 Added 0.21%	193,551 $104 Million
Q2 2023 Aug 03, 2023	SELL	$350.74 - $468.98 $1.86 Million - $2.49 Million	-5,300 Reduced 2.67%	193,151 $90.6 Million
Q1 2023 Apr 21, 2023	SELL	$310.63 - $364.82 $5.09 Million - $5.98 Million	-16,400 Reduced 7.63%	198,451 $68.2 Million
Q4 2022 Feb 02, 2023	BUY	$321.55 - $374.67 $10 Million - $11.7 Million	31,200 Added 16.99%	214,851 $78.6 Million
Q3 2022 Oct 17, 2022	BUY	$296.48 - $337.87 $5.84 Million - $6.66 Million	19,700 Added 12.02%	183,651 $59.4 Million
Q2 2022 Aug 11, 2022	SELL	$278.73 - $327.27 $1.11 Million - $1.31 Million	-4,000 Reduced 2.38%	163,951 $53.2 Million
Q1 2022 May 09, 2022	SELL	$234.69 - $291.66 $5.89 Million - $7.32 Million	-25,100 Reduced 13.0%	167,951 $48.1 Million
Q4 2021 Feb 11, 2022	SELL	$224.85 - $279.04 $2.95 Million - $3.66 Million	-13,100 Reduced 6.35%	193,051 $53.3 Million
Q3 2021 Nov 10, 2021	BUY	$221.6 - $272.71 $6.05 Million - $7.44 Million	27,300 Added 15.26%	206,151 $47.6 Million
Q2 2021 Aug 12, 2021	BUY	$180.55 - $233.54 $1.66 Million - $2.15 Million	9,200 Added 5.42%	178,851 $41.1 Million
Q1 2021 May 11, 2021	BUY	$164.32 - $212.72 $640,848 - $829,608	3,900 Added 2.35%	169,651 $31.7 Million
Q4 2020 Feb 09, 2021	BUY	$130.46 - $172.63 $2.18 Million - $2.88 Million	16,700 Added 11.2%	165,751 $28 Million
Q3 2020 Feb 19, 2021	BUY	$146.22 - $169.13 $21.8 Million - $25.2 Million	149,051 New	149,051 $22.1 Million
Q3 2020 Oct 22, 2020	SELL	$146.22 - $169.13 $22 Million - $25.5 Million	-150,710 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$136.42 - $164.18 $3.56 Million - $4.29 Million	26,100 Added 20.95%	150,710 $24.7 Million
Q1 2020 May 04, 2020	SELL	$119.05 - $147.35 $16.4 Million - $20.3 Million	-137,800 Reduced 52.51%	124,610 $17.3 Million
Q4 2019 Feb 12, 2020	SELL	$106.92 - $132.43 $2.58 Million - $3.19 Million	-24,100 Reduced 8.41%	262,410 $34.5 Million
Q3 2019 Nov 13, 2019	BUY	$106.79 - $116.16 $3.37 Million - $3.67 Million	31,600 Added 12.4%	286,510 $32 Million
Q2 2019 Aug 07, 2019	SELL	$110.79 - $129.32 $332,370 - $387,960	-3,000 Reduced 1.16%	254,910 $28.2 Million
Q1 2019 May 08, 2019	SELL	$111.31 - $131.02 $17.7 Million - $20.8 Million	-158,841 Reduced 38.11%	257,910 $33.5 Million
Q4 2018 Feb 11, 2019	BUY	$105.9 - $118.64 $1.39 Million - $1.55 Million	13,100 Added 3.25%	416,751 $48.2 Million
Q3 2018 Nov 07, 2018	BUY	$85.86 - $107.31 $1.66 Million - $2.07 Million	19,300 Added 5.02%	403,651 $43.3 Million
Q2 2018 Aug 15, 2018	SELL	$75.7 - $86.88 $1.99 Million - $2.28 Million	-26,257 Reduced 6.39%	384,351 $32.8 Million
Q3 2017 Oct 31, 2017	BUY	$77.07 - $85.54 $31.6 Million - $35.1 Million	410,608	410,608 $35.1 Million

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Forsta Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Forsta Ap Fonden with notifications on news.

Account